|
Re: SF
|
5
|
Resverlogix Corp.
|
Sep 16, 2020 03:01PM
|
|
Re: secondary readouts...
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 02:25PM
|
|
Re: Scientists Develop a New Molecule That Blocks COVID-19 Infection.
|
9
|
Resverlogix Corp.
|
Dec 15, 2021 09:13AM
|
|
Re: RVX is warming up!
|
2
|
Resverlogix Corp.
|
Jan 26, 2022 10:08AM
|
|
Re: RVX is
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 10:29AM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
2
|
Resverlogix Corp.
|
Jan 18, 2021 07:52AM
|
|
Re: RSU's awarded
|
1
|
Resverlogix Corp.
|
Sep 19, 2019 01:37PM
|
|
Re: Round one
|
4
|
Resverlogix Corp.
|
Jan 27, 2022 09:12AM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 02:30PM
|
|
Re: Risk vs Reward moving forward!
|
2
|
Resverlogix Corp.
|
Dec 17, 2021 02:44PM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 02:56PM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 03:01PM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 03:17PM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 04:01PM
|
|
Re: Risk vs Reward moving forward!
|
|
Resverlogix Corp.
|
Dec 17, 2021 04:08PM
|
|
Re: Risk vs Reward moving forward!
|
1
|
Resverlogix Corp.
|
Dec 17, 2021 04:33PM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
2
|
Resverlogix Corp.
|
Jul 08, 2019 09:28AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 24, 2020 08:31AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 24, 2020 09:27AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 26, 2020 09:58AM
|
